At a glance
- Originator FAES Farma
- Class Antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypersensitivity; Respiratory tract disorders
Most Recent Events
- 11 Nov 1996 Discontinued-Preclinical for Allergy in Spain (Unknown route)
- 18 Jan 1996 Discontinued-Preclinical for Respiratory tract disorders in Spain (Unknown route)